1. Home
  2. RECT vs INTS Comparison

RECT vs INTS Comparison

Compare RECT & INTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rectitude Holdings Ltd

RECT

Rectitude Holdings Ltd

N/A

Current Price

$1.59

Market Cap

22.6M

Sector

N/A

ML Signal

N/A

Logo Intensity Therapeutics Inc.

INTS

Intensity Therapeutics Inc.

HOLD

Current Price

$0.34

Market Cap

24.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RECT
INTS
Founded
1997
2012
Country
Singapore
United States
Employees
111
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
22.6M
24.0M
IPO Year
2024
2023

Fundamental Metrics

Financial Performance
Metric
RECT
INTS
Price
$1.59
$0.34
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$2.25
AVG Volume (30 Days)
5.8K
1.2M
Earning Date
02-20-2026
03-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.12
N/A
Revenue
$32,594,177.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$13.17
N/A
Revenue Growth
5.91
N/A
52 Week Low
$1.30
$0.19
52 Week High
$6.04
$2.53

Technical Indicators

Market Signals
Indicator
RECT
INTS
Relative Strength Index (RSI) 36.76 31.99
Support Level $1.51 $0.37
Resistance Level $1.72 $0.39
Average True Range (ATR) 0.14 0.02
MACD -0.00 -0.01
Stochastic Oscillator 41.67 0.19

Price Performance

Historical Comparison
RECT
INTS

About RECT Rectitude Holdings Ltd

Rectitude Holdings Ltd is principally involved in the provision of safety equipment, encompassing essential items such as personal protective clothing, hand gloves, safety footwear, and personal fall arrest systems (a system used to arrest an employee in a fall from a walking-working surface, usually consisting of a body harness, anchorage, and connector), portable fire extinguishers and traffic products such as rubber speed humps, wheel stops and wheel chocks. Additionally the company has added auxiliary products such as industrial hardware tools and electrical hardware required for construction sites.

About INTS Intensity Therapeutics Inc.

Intensity Therapeutics Inc is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. The company leverages its DfuseRxtechnology platform to create new, proprietary drug formulations that, following direct injection, rapidly disperse throughout a tumor and diffuse therapeutic agents into cancer cells. Intensity's product candidates have the potential to induce an adaptive systemic immune response that not only attacks the injected tumor, but also non-injected tumors. Their pipeline is focused on realizing the full potential of INT230-6 in metastatic and local disease settings to help cancer patients with unmet medical need.

Share on Social Networks: